ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casas, A.
Right arrow Articles by Rodríguez-Roisin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casas, A.
Right arrow Articles by Rodríguez-Roisin, R.
Eur Respir J 2005; 26:442-448
Copyright ©ERS Journals Ltd 2005

Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor

A. Casas1,+, F. P. Gómez1,+, B. Dahlén2, J. Roca1, J. A. Barberà1, S-E. Dahlén2 and R. Rodríguez-Roisin1

1 Servei de Pneumologia, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain, 2 Dept of Internal Medicine at Huddinge University Hospital and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

CORRESPONDENCE: R. Rodriguez-Roisin, Servei de Pneumologia, Hospital Clínic, Villarroel, 170. 08036-Barcelona, Spain. Fax: 34 932275404. E-mail: rororo@clinic.ub.es

Keywords: Leukotriene inhalation challenge, leukotriene receptor antagonists, ventilation-perfusion mismatching

Received: December 23, 2004
Accepted May 10, 2005

Bronchoprovocation with cysteinyl-leukotrienes (LTs) induces airflow obstruction and gas exchange abnormalities, namely ventilation-perfusion ratio (V'A/Q') imbalance. However, it is unknown which of the two different receptors for cysteinyl-LTs mediate these V'A/Q' disturbances.

In a double-blinded, crossover design, 10 patients with mild asthma were randomised to receive an oral single dose of the selective cysteinyl-LT1 receptor antagonist montelukast (40 mg) or placebo before leukotriene (LT)D4 inhalation challenge. Gas exchange, including V'A/Q' descriptors were measured at baseline, 3 h after montelukast/placebo pretreatment and 5, 15 and 45 min after the LTD4 challenge.

Compared with montelukast, inhalation of LTD4 induced a marked fall in forced expiratory volume in one second (mean±SE 33±2%) and profound V'A/Q' mismatching, reflected by a decreased arterial oxygen tension (from 100±4 to 75±3 mmHg) and an increased overall index of V'A/Q' heterogeneity dispersion of retention minus excretion inert gases corrected for dead space (from 4.9±1.2 to 8.4±1.1; normal≤3.0; dimensionless), 5 min after placebo. Following montelukast, LTD4 produced no significant changes in any of the variables.

In conclusion, these findings point to the view that leukotriene D4-induced gas exchange disturbances and bronchoconstriction are both mediated by the cysteinyl-leukotriene1 receptor.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the European Respiratory Society.